359 related articles for article (PubMed ID: 10733543)
1. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
[TBL] [Abstract][Full Text] [Related]
2. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay.
Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ
Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibodies to acetaldehyde-albumin conjugates in alcoholic liver disease.
Teare JP; Carmichael AJ; Burnett FR; Rake MO
Alcohol Alcohol; 1993 Jan; 28(1):11-6. PubMed ID: 8471080
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects.
Worrall S; De Jersey J; Shanley BC; Wilce PA
Alcohol Alcohol; 1990; 25(5):509-17. PubMed ID: 1708257
[TBL] [Abstract][Full Text] [Related]
6. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
Yokoyama H
Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
[TBL] [Abstract][Full Text] [Related]
7. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
Viitala K; Israel Y; Blake JE; Niemelä O
Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
[TBL] [Abstract][Full Text] [Related]
8. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
9. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant.
Thiele GM; Tuma DJ; Willis MS; Miller JA; McDonald TL; Sorrell MF; Klassen LW
Alcohol Clin Exp Res; 1998 Nov; 22(8):1731-9. PubMed ID: 9835288
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats.
Xu D; Thiele GM; Beckenhauer JL; Klassen LW; Sorrell MF; Tuma DJ
Gastroenterology; 1998 Sep; 115(3):686-92. PubMed ID: 9721166
[TBL] [Abstract][Full Text] [Related]
11. Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates.
Latvala J; Melkko J; Parkkila S; Järvi K; Makkonen K; Niemelä O
Alcohol Clin Exp Res; 2001 Nov; 25(11):1648-53. PubMed ID: 11707639
[TBL] [Abstract][Full Text] [Related]
12. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers.
Vidali M; Hietala J; Occhino G; Ivaldi A; Sutti S; Niemelä O; Albano E
Free Radic Biol Med; 2008 Aug; 45(3):306-11. PubMed ID: 18460346
[TBL] [Abstract][Full Text] [Related]
13. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation.
Willis MS; Klassen LW; Tuma DJ; Sorrell MF; Thiele GM
Alcohol Clin Exp Res; 2002 Jan; 26(1):94-106. PubMed ID: 11821659
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.
Niemelä O; Juvonen T; Parkkila S
J Clin Invest; 1991 Apr; 87(4):1367-74. PubMed ID: 1707062
[TBL] [Abstract][Full Text] [Related]
15. Protein adduct species in muscle and liver of rats following acute ethanol administration.
Patel VB; Worrall S; Emery PW; Preedy VR
Alcohol Alcohol; 2005; 40(6):485-93. PubMed ID: 16131499
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against malondialdehyde-acetaldehyde adducts can help identify patients with abdominal aortic aneurysm.
Carson JS; Xiong W; Dale M; Yu F; Duryee MJ; Anderson DR; Thiele GM; Baxter BT
J Vasc Surg; 2016 Feb; 63(2):477-84. PubMed ID: 25724613
[TBL] [Abstract][Full Text] [Related]
17. Antibodies made against a formaldehyde-protein adduct cross react with an acetaldehyde-protein adduct. Implications for the origin of antibodies in human serum which recognize acetaldehyde-protein adducts.
Pietrzak ER; Shanley BC; Kroon PA
Alcohol Alcohol; 1995 May; 30(3):373-8. PubMed ID: 7545992
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin-acetaldehyde adducts in human alcohol abusers.
Niemelä O; Israel Y
Lab Invest; 1992 Aug; 67(2):246-52. PubMed ID: 1380106
[TBL] [Abstract][Full Text] [Related]
19. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis.
Holstege A; Bedossa P; Poynard T; Kollinger M; Chaput JC; Houglum K; Chojkier M
Hepatology; 1994 Feb; 19(2):367-74. PubMed ID: 7507463
[TBL] [Abstract][Full Text] [Related]
20. Conversion of acetaldehyde-protein adduct epitopes from a nonreduced to a reduced phenotype by antigen processing cells.
Klassen LW; Jones BL; Sorrell MF; Tuma DJ; Thiele GM
Alcohol Clin Exp Res; 1999 Apr; 23(4):657-63. PubMed ID: 10235301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
